AI
| Followers | 2539 |
| Posts | 250759 |
| Boards Moderated | 35 |
| Alias Born | 05/06/2014 |
Tuesday, September 20, 2016 5:23:05 AM
$ARLZ Guggenheim Reiterates Buy on Aralez Pharma (ARLZ) Following Yosprala Approval
Guggenheim reiterated a Buy rating and $12.00 price target on Aralez Pharmaceuticals (NASDAQ: ARLZ) following the approval of Yosprala and the recent acquisition of Zontivity
http://www.streetinsider.com/Analyst+Comments/Guggenheim+Reiterates+Buy+on+Aralez+Pharma+(ARLZ)+Following+Yosprala+Approval/12037074.html
Go $ARLZ
Guggenheim reiterated a Buy rating and $12.00 price target on Aralez Pharmaceuticals (NASDAQ: ARLZ) following the approval of Yosprala and the recent acquisition of Zontivity
http://www.streetinsider.com/Analyst+Comments/Guggenheim+Reiterates+Buy+on+Aralez+Pharma+(ARLZ)+Following+Yosprala+Approval/12037074.html
Go $ARLZ
investorshub.advfn.com/$Pistol-Pete$-$Mick$-&-Friends-Stock-Picks-29568/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
